CrowdStrike, Mobix Labs, Micron Technology, Target And Moderna: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks finished Tuesday lower as mounting tensions in the conflict with Iran weighed on sentiment. The Dow Jones Industrial Average slid 0.8% to 48,501.27, the S&P 500 dropped 0.9% to 6,816.63, and the Nasdaq Composite fell 1.02% to 22,516.69

These are the top stocks that gained the attention of retail traders and investors through the day.

CrowdStrike Holdings Inc. (NASDAQ:CRWD)

CrowdStrike stock climbed 1.70% to close at $391.42, with an intraday high of $394.92 and low of $367.99, between a 52-week high of $566.90 and a low of $298.14.

The cybersecurity firm reported fourth-quarter revenue of $1.31 billion, surpassing estimates, while subscription revenue rose 23% year-over-year and annual recurring revenue hit $5.25 billion, as its CEO highlighted a massive growth opportunity from AI adoption across enterprise layers.

Mobix Labs, Inc. (NASDAQ:MOBX)

Mobix Labs shares skyrocketed 532.77% to $1.12, reaching an intraday high of $1.24 and a low of $0.39, within a 52-week range of $1.44 high and $0.13 low. In the after-hours trading, the stock rose 5.36% to $1.18.

Shares surged after the company secured a production purchase order for its high-reliability filtering components essential to the U.S. Navy’s Tomahawk cruise missile program, underscoring rising demand from ongoing missile manufacturing schedules, according to CEO Phil Sansone.

Micron Technology Inc (NASDAQ:MU)

Micron dropped 7.99% to $379.68, with a high of $390.09 and a low of $374.55, against a 52-week high of $455.48 and a low of $61.54.

The memory chip maker shipped customer samples of its pioneering 256GB SOCAMM2 module despite broader semiconductor weakness, as analysts, including Timothy Arcuri from UBS and Brian Chin from Stifel, raised price targets amid its push into AI data center innovations.

Target Corporation (NYSE:TGT)

Target stock advanced 6.77% to $120.80, hitting a high and low of $122.43 and $115 intraday, between a 52-week high of $122.43 and low of $83.44.

The retailer exceeded profit expectations with adjusted earnings of $2.44 per share despite a slight sales dip, as categories like food, beauty and toys drove growth and gross margins improved to 26.6% through lower costs and advertising gains.

Moderna Inc (NASDAQ:MRNA)

Moderna fell 5.71% to $49.83, with an intraday high of $51.86 and low of $48.09, within a 52-week high of $55.19 and low of $22.29. The stock shot up 8.35% to $53.99 in the after-hours trading.

The biotech company settled global patent litigation with Arbutus Biopharma and Genevant Sciences over Spikevax and mRESVIA, agreeing to a $950 million payment while appealing for immunity, as CEO Stéphane Bancel noted it clears the path for focus on its infectious disease pipeline.

Benzinga Edge Stock Rankings indicate CrowdStrike stock has a Momentum in the 18th percentile.

This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal

Photo Courtesy: StockPhotos.GALLERY on Shutterstock.com